Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Robinson

Showing results (121-130 of 143) with videos related to

Pageof 15
Sort By:
Bone Marrow Transplantation|February 27, 2019
Autologous stem cell transplantation for HIV-associated lymphoma in the antiretroviral and rituximab era: a retrospective study by the EBMT Lymphoma Working PartyKai Hübel, Alessandro Re, Ariane Boumendil, et al.
Nucleic Acids Research|November 4, 2008
Petabyte-scale innovations at the European Nucleotide ArchiveGuy Cochrane, Ruth Akhtar, James Bonfield, et al.
American Journal of Hematology|October 18, 2018
Impact of T-cell depletion strategies on outcomes following hematopoietic stem cell transplantation for idiopathic aplastic anemia: A study on behalf of the European blood and marrow transplant severe aplastic anemia working partySujith Samarasinghe, Katherine Clesham, Simona Iacobelli, et al.
Bone Marrow Transplantation|April 7, 2021
Outcomes following second allogeneic haematopoietic cell transplantation in patients with myelofibrosis: a retrospective study of the Chronic Malignancies Working Party of EBMTMitja Nabergoj, Katya Mauff, Marie Robin, et al.
Cancer|October 24, 2018
Brentuximab vedotin for recurrent Hodgkin lymphoma after allogeneic hematopoietic stem cell transplantation: A report from the EBMT Lymphoma Working PartyAli Bazarbachi, Ariane Boumendil, Hervé Finel, et al.
British Journal of Haematology|October 3, 2023
Cord blood transplantation for AML: Comparable LFS in patients with de novo versus secondary AML in CR1, an ALWP/EBMT studyFrédéric Baron, Arnon Nagler, Jacques-Emmanuel Galimard, et al.
Bone Marrow Transplantation|October 8, 2021
Correction: Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an EBMT surveyLeopold Sellner, Johannes Schetelig, Linda Koster, et al.
Bone Marrow Transplantation|May 24, 2020
Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an EBMT surveyLeopold Sellner, Johannes Schetelig, Linda Koster, et al.
British Journal of Haematology|September 10, 2019
Influence of donor type, stem cell source and conditioning on outcomes after haploidentical transplant for lymphoma - a LWP-EBMT studyAli Bazarbachi, Ariane Boumendil, Hervé Finel, et al.
Bone Marrow Transplantation|May 13, 2024
Correction: Treosulfan compared to busulfan in allogeneic haematopoietic stem cell transplantation for myelofibrosis: a registry-based study from the Chronic Malignancies Working Party of the EBMTMarie Robin, Simona Iacobelli, Linda Koster, et al.
Pageof 15

Showing results (121-130 of 143) with videos related to

Sort By:
Pageof 15
Bone Marrow Transplantation|February 27, 2019
Autologous stem cell transplantation for HIV-associated lymphoma in the antiretroviral and rituximab era: a retrospective study by the EBMT Lymphoma Working PartyKai Hübel, Alessandro Re, Ariane Boumendil, et al.
Nucleic Acids Research|November 4, 2008
Petabyte-scale innovations at the European Nucleotide ArchiveGuy Cochrane, Ruth Akhtar, James Bonfield, et al.
American Journal of Hematology|October 18, 2018
Impact of T-cell depletion strategies on outcomes following hematopoietic stem cell transplantation for idiopathic aplastic anemia: A study on behalf of the European blood and marrow transplant severe aplastic anemia working partySujith Samarasinghe, Katherine Clesham, Simona Iacobelli, et al.
Bone Marrow Transplantation|April 7, 2021
Outcomes following second allogeneic haematopoietic cell transplantation in patients with myelofibrosis: a retrospective study of the Chronic Malignancies Working Party of EBMTMitja Nabergoj, Katya Mauff, Marie Robin, et al.
Cancer|October 24, 2018
Brentuximab vedotin for recurrent Hodgkin lymphoma after allogeneic hematopoietic stem cell transplantation: A report from the EBMT Lymphoma Working PartyAli Bazarbachi, Ariane Boumendil, Hervé Finel, et al.
British Journal of Haematology|October 3, 2023
Cord blood transplantation for AML: Comparable LFS in patients with de novo versus secondary AML in CR1, an ALWP/EBMT studyFrédéric Baron, Arnon Nagler, Jacques-Emmanuel Galimard, et al.
Bone Marrow Transplantation|October 8, 2021
Correction: Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an EBMT surveyLeopold Sellner, Johannes Schetelig, Linda Koster, et al.
Bone Marrow Transplantation|May 24, 2020
Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an EBMT surveyLeopold Sellner, Johannes Schetelig, Linda Koster, et al.
British Journal of Haematology|September 10, 2019
Influence of donor type, stem cell source and conditioning on outcomes after haploidentical transplant for lymphoma - a LWP-EBMT studyAli Bazarbachi, Ariane Boumendil, Hervé Finel, et al.
Bone Marrow Transplantation|May 13, 2024
Correction: Treosulfan compared to busulfan in allogeneic haematopoietic stem cell transplantation for myelofibrosis: a registry-based study from the Chronic Malignancies Working Party of the EBMTMarie Robin, Simona Iacobelli, Linda Koster, et al.
Pageof 15